标题
Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 13, Issue 9, Pages 1315-1323
出版商
Informa Healthcare
发表日期
2013-07-02
DOI
10.1517/14712598.2013.813478
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Improvement of ischemic cholangiopathy in three patients with hereditary hemorrhagic telangiectasia following treatment with bevacizumab
- (2013) Paraskevi A. Vlachou et al. JOURNAL OF HEPATOLOGY
- Systemic therapy with bevacizumab in patients with hereditary hemorrhagic telangiectasia (HHT)
- (2013) Ajay Chavan et al. Vasa-European Journal of Vascular Medicine
- Iron Deficiency Anemia Related to Hereditary Hemorrhagic Telangiectasia: Response to Treatment With Bevacizumab
- (2012) Jessica M. Fleagle et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Bevacizumab treatment in hereditary hemorrhagic teleangiectasia
- (2012) Sebastian Föllner et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output
- (2012) Sophie Dupuis-Girod et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bevacizumab as Rescue Treatment for Severe Recurrent Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia
- (2012) Alexandru Lupu et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Bevacizumab nasal spray: Noninvasive treatment of epistaxis in patients with rendu-osler disease
- (2012) Romain Guldmann et al. LARYNGOSCOPE
- Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: Effectiveness of an injection protocol based on the vascular anatomy of the nose
- (2012) Sinan Dheyauldeen et al. LARYNGOSCOPE
- Low Dose of Bevacizumab Is Safe and Effective in Preventing Bleeding Episodes in Hereditary Hemorrhagic Telangiectasia
- (2011) Georgia Lazaraki et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Intravenous and topical intranasal bevacizumab (Avastin) in hereditary hemorrhagic telangiectasia
- (2011) Brian T. Brinkerhoff et al. AMERICAN JOURNAL OF OTOLARYNGOLOGY
- Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia
- (2011) Scott E. Olitsky AMERICAN JOURNAL OF OTOLARYNGOLOGY
- Individualized therapy of HHT driven by network analysis of metabolomic profiles
- (2011) Neema Jamshidi et al. BMC Systems Biology
- A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia
- (2011) C. Rohrmeier et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Treatment-Related Mortality With Bevacizumab in Cancer Patients
- (2011) Vishal Ranpura et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy
- (2011) Tom T. Karnezis et al. LARYNGOSCOPE
- Long-Term Therapy with Bevacizumab in Hereditary Hemorrhagic Telangiectasia
- (2011) Brian T. Brinkerhoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
- (2010) Philip Fodstad et al. ANNALS OF HEMATOLOGY
- Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment
- (2010) Claire L. Shovlin BLOOD REVIEWS
- Low dose intravenous bevacizumab for the treatment of anaemia in hereditary haemorrhagic telangiectasia
- (2010) Suppressa Patrizia et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hereditary hemorrhagic telangiectasia: from molecular biology to patient care
- (2010) S. DUPUIS-GIROD et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Safety of intranasal Bevacizumab (avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis
- (2010) Sonia Chen et al. LARYNGOSCOPE
- Efficacy of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis
- (2010) Tom T. Karnezis et al. LARYNGOSCOPE
- Hereditary haemorrhagic telangiectasia: a clinical and scientific review
- (2009) Fatima S Govani et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia
- (2009) M. E. Faughnan et al. JOURNAL OF MEDICAL GENETICS
- Effects of VEGF on Phenotypic Severity in Children With Hereditary Hemorrhagic Telangiectasia
- (2009) Paola Giordano et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia
- (2009) Jana Simonds et al. LARYNGOSCOPE
- Bevacizumab in Hereditary Hemorrhagic Telangiectasia
- (2009) Prithviraj Bose et al. NEW ENGLAND JOURNAL OF MEDICINE
- More on Bevacizumab in Hereditary Hemorrhagic Telangiectasia
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Post-NICE 2008: antibiotic prophylaxis prior to dental procedures for patients with pulmonary arteriovenous malformations (PAVMs) and hereditary haemorrhagic telangiectasia
- (2008) C. Shovlin et al. BRITISH DENTAL JOURNAL
- Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: Echo-color-Doppler vs multislice computed tomography study
- (2008) Paolo Buonamico et al. JOURNAL OF HEPATOLOGY
- Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia
- (2008) Andrew Mitchell et al. LIVER TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now